The Long and Evolving Relationship between Viruses and Multiple Sclerosis

• Compston A , ColesA. Multiple sclerosis. Lancet372 , 1502–1517 (2008).
   PubMed Web of Science ®Google Scholar
• Weiner HL . Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol.61 , 1613–1615 (2004).
   PubMed Web of Science ®Google Scholar
• Roach ES . Is multiple sclerosis an autoimmune disorder? Arch. Neurol.61 , 1615–1616 (2004).
   PubMedGoogle Scholar
• Zamvil SS , SteinmanL. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol.8 , 579–621 (1990).
   PubMed Web of Science ®Google Scholar
• Gran B , HemmerB, VergelliM, McFarlandHF, MartinR. Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann. Neurol.45(5) , 559–567 (1999).
   PubMed Web of Science ®Google Scholar
• Hemmer B , NesslerS, ZhouD, KieseierB, HartungHP. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat. Clin. Pract. Neurol.2(4) , 201–211 (2006).
   PubMedGoogle Scholar
• Poskanzer DC , OksenbergJR. The neurobiology of multiple sclerosis: genes, inflammation and neurodegeneration. Neuron52 , 61–76 (2006).
   PubMed Web of Science ®Google Scholar
• Herna MA , ZhangSM, LipworthL et al. Multiple Sclerosis and age at infection with common viruses. Epidemiology 13 , 301–306 (2001).
   Google Scholar
• Kurtzke JF . Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microb. Rev.6(4) , 382–427 (1993).
   PubMed Web of Science ®Google Scholar
• Kurtzke JF , HeltbergA. Multiple sclerosis in the Faroe Islands: an epitome. J. Clin. Epidemiol.54 , 1–22 (2001).
   PubMed Web of Science ®Google Scholar
• Poskanzer DC , SchapiraK, MillerH. Multiple sclerosis and poliomyelitis. Lancet2 , 917–921 (1963).
   PubMed Web of Science ®Google Scholar
• Zilber N , Kutai-BermanM, KahanaE, KorczynAD. Multiple sclerosis and birth order. Acta Neurol. Scand.78 , 313–317 (1988).
   PubMed Web of Science ®Google Scholar
• Martyn CN . The epidemiology of multiple sclerosis. In: McAlpine‘s Multiple Sclerosis. Matthews WB, Compston A, Allen IV, Martyn CN (Eds). Churchill Livingstone, PA, USA (1991).
   Google Scholar
• Bansil S , TroianoR, Rohowsky-KochanC et al. Multiple sclerosis: pathogenesis and treatment. Semin. Neurol. 14(2) , 146–153 (1994).
   PubMed Web of Science ®Google Scholar
• Oleszak EL , ChangJR, FriedmanH, KatsetosCD, PlatsoucasCD. Theiler‘s virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev.17(1) , 174–207 (2004).
   PubMed Web of Science ®Google Scholar
• Tsunoda I , FujinamiRS. Neuropathogenesis of Theiler‘s murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J. Neuroimmune. Pharmacol.5(3) , 355–369 (2010).
   PubMed Web of Science ®Google Scholar
• Pawate S , SriramS. The role of infections in the pathogenesis and course of multiple sclerosis. Ann. Indian. Acad. Neurol.13(2) , 80–86 (2010).
   PubMed Web of Science ®Google Scholar
• Hunter SF , HaflerDA. Ubiquitous pathogens: links between infection and autoimmunity in MS? Neurology55(2) , 164–165 (2000).
   PubMed Web of Science ®Google Scholar
• Fujinami RS , OldstoneMB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science230 , 1043–1045 (1985).
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW , StromingerJL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell80 , 695–705 (1995).
   PubMed Web of Science ®Google Scholar
• Olson JK , CroxfordJL, CalenoffMA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest.108(2) , 311–318 (2001).
   PubMed Web of Science ®Google Scholar
• Lang HL , JacobsenH, IkemizuS et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3(10) , 940–943 (2002).
   PubMed Web of Science ®Google Scholar
• Jilek S , KuhleJ, MeylanP et al. Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response. J. Neuroimmunol. 192 , 192–197 (2007).
   PubMed Web of Science ®Google Scholar
• Lünemann JD , JelcicI, RobertsS et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce INF-gamma and IL-2. J. Exp. Med. 205 , 1763–1773 (2008).
   PubMed Web of Science ®Google Scholar
• Challoner PB , SmithKT, ParkerJD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl Acad. Sci. USA 92(16) , 7440–7444 (1995).
   PubMed Web of Science ®Google Scholar
• Buljevac D , van Doornum GJ, Flach HZ et al. Epstein–Barr virus and disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry76(10) , 1377–1381 (2005).
   PubMed Web of Science ®Google Scholar
• Ordoñez G , PinedaB, Garcia-NavarreteR, SoteloJ. Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis. Arch. Neurol.61(4) , 529–532 (2004).
   PubMedGoogle Scholar
• Ross RT , CheangM. Geographic similarities between varicella and multiple sclerosis: an hypothesis on the environmental factor of multiple sclerosis. J. Clin. Epidemiol.48 , 731–737 (1995).
   PubMed Web of Science ®Google Scholar
• Marrie RA , WolfsonC. Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol. Infect.127 , 315–325 (2001).
   PubMed Web of Science ®Google Scholar
• Mancuso R , DelbueS, BorghiE et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J. Med. Virol. 79(2) , 192–199 (2007).
   PubMed Web of Science ®Google Scholar
• Mancuso R , HernisA, CavarrettaR et al. Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis. J. Med. Virol. 82(6) , 1051–1057 (2010).
   PubMed Web of Science ®Google Scholar
• Kang JH , SheuJJ, KaoS, LinHC. Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study. J. Infect. Dis.204 , 188–192 (2011).
   PubMed Web of Science ®Google Scholar
• Sotelo J , CoronaT. Varicella zoster virus and relapsing remitting multiple sclerosis. Mult. Scler. Int.2147–2163 (2011).
   Google Scholar
• Mainka C , FussB, GeigerH, HöfelmayrH, WolffMH. Characterization of viremia at different stages of Varicella zoster virus infection. J. Med. Virol.56(1) , 91–98 (1998).
   PubMed Web of Science ®Google Scholar
• Pineda B , SanigerMDM, Chánez-CárdenasME et al. Solid-phase assay for the detection of varicella zoster virus. Future Virol. 4(6) , 543–551 (2009).
   Web of Science ®Google Scholar
• Burgoon MP , CohrsRJ, BennettJL et al. Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis. Ann. Neurol. 65(4) , 474–479 (2009).
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK , GildenDH. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch. Pathol. Lab. Med.125(6) , 770–780 (2001).
   PubMed Web of Science ®Google Scholar
• Yuki N . Infectious origins of, and molecular mimicry in, Guillain–Barré and Fisher syndromes. Lancet Infect. Dis.1(1) , 29–37 (2001).
   PubMedGoogle Scholar
• Scarisbrick IA , RodriguezM. Hit–hit and hit–run: viruses in the playing field of multiple sclerosis. Curr. Neurol. Neurosci. Rep.3(3) , 265–271 (2003).
   PubMedGoogle Scholar
• Braun DK , DominguezG, PellettPE. Human herpesvirus 6. Clin. Microb. Rev.10 , 521–567 (1997).
   PubMed Web of Science ®Google Scholar
• Dockrell DH , SmithTF, PayaCV. Human herpes virus 6. Mayo. Clin. Proc.74 , 163–170 (1999).
   PubMed Web of Science ®Google Scholar
• Meinl E . Concepts of viral pathogenesis of multiple sclerosis. Curr. Opin. Neurol.12 , 303–307 (1999).
   PubMed Web of Science ®Google Scholar
• Kakalacheva K , LünemannJD. Environmental triggers of multiple sclerosis. FEBS Lett.585(23) , 3724–3729 (2011).
   PubMed Web of Science ®Google Scholar
• Moore FG , WolfsonC. Human herpes virus 6 and multiple sclerosis. Acta Neurol. Scand.106(2) , 63–83 (2002).
   PubMed Web of Science ®Google Scholar
• Voumvourakis KI , KitsosDK, TsiodrasS, PetrikkosG, StamboulisE. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin. Proc.85(11) , 1023–1030 (2010).
   PubMed Web of Science ®Google Scholar
• Kieff ED , RickinsonAB. Epstein–Barr virus and its replication. In: Fields Virology Volume 2. Knipe DM, Howley PM (Eds). Wolters Kluwer Health/Lippincott Williams & Wilkins, PA, USA, 2603–2654 (2007).
   Google Scholar
• Lucas RM , HughesAM, LayML et al. Epstein–Barr virus and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 82(10) , 1142–1148 (2011).
   PubMed Web of Science ®Google Scholar
• Ascherio A , MungerKL Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol.61(4) , 288–299 (2007).
   PubMed Web of Science ®Google Scholar
• Nielsen TR , RostgaardK, NielsenNM et al. Multiple sclerosis after infectious mononucleosis. Arch. Neurol. 64(1) , 72–75 (2007).
   PubMedGoogle Scholar
• Takeuchi K , Tanaka-TayaK, KazuyamaY et al. Prevalence of Epstein–Barr virus in Japan: trends and future prediction. Pathol. Int. 56(3) , 112–116 (2006).
   PubMed Web of Science ®Google Scholar
• Melbye M Ebbesen P, Levine PH et al. Early primary infection and high Epstein–Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma. Int. J. Cancer.34 , 619–623 (1984).
   PubMed Web of Science ®Google Scholar
• Ahlgren C , TorenK, OdenA et al. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur. J. Epidemiol. 24 , 541–552 (2009).
   PubMed Web of Science ®Google Scholar
• Thacker EL Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol.59(3) , 499–503 (2006).
   PubMed Web of Science ®Google Scholar
• Ascherio A , MungerKL. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein–Barr virus and multiple sclerosis: epidemiological evidence. Clin. Exp. Immunol.160(1) , 120–124 (2010).
   PubMed Web of Science ®Google Scholar
• DeLorenze GN , MungerKL, LennetteE, OrentreichN, VogelmanJ, AscherioA. Epstein–Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch. Neurol.63(6) , 839–844 (2006).
   PubMedGoogle Scholar
• Klutts JS , FordBA, PerezNR et al. Evidence-based approach for interpretation of Epstein–Barr virus serological patterns. J. Clin. Microbiol. 47 , 3204–3210 (2009).
   PubMed Web of Science ®Google Scholar
• Cepok S , ZhouD, SrivastavaR, NesslerS et al. Identification of Epstein–Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 115(5) , 1352–1360 (2005).
   PubMed Web of Science ®Google Scholar
• Jaquiery E , JilekS, SchluepM et al. Intrathecal immune responses to EBV in early MS. Eur. J. Immunol. 40 , 878–887 (2010).
   PubMed Web of Science ®Google Scholar
• Larsen PD , BloomerLC, BrayPF. Epstein–Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology35 , 435– 438 (1985).
   PubMed Web of Science ®Google Scholar
• Shirodaria PV , HaireM, FlemingE et al. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch. Neurol. 44 , 1237–1241 (1987).
   PubMedGoogle Scholar
• Zivadinov R , ZorzonM, Weinstock-GuttmanB et al. Epstein–Barr virus is associated with gray matter atrophy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 80(6) , 620–625 (2009).
   PubMed Web of Science ®Google Scholar
• Farrell RA , AntonyD, WallGR et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73(1) , 32–38 (2009).
   PubMed Web of Science ®Google Scholar
• Ben Fredj N , RotolaA, NefziF et al. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J. Neurovirol. 18(1) , 12–19 (2012).
   PubMed Web of Science ®Google Scholar
• Ferrante P , Omodeo-ZoriniE, ZuffolatoMR et al. Human T-cell lymphotropic virus tax and Epstein–Barr virus DNA in peripheral blood of multiple sclerosis patients during acute attack. Acta Neurol. Scand. 169 , 79–85 (1997).
   Google Scholar
• Lunemann JD , HuppkeP, RobertsS et al. Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology 71 , 1033–1035 (2008).
   PubMed Web of Science ®Google Scholar
• Alvarez-Lafuente R , García-MontojoM, De las Heras V, Bartolomé M, Arroyo R. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. J. Clin. Virol.37(Suppl. 1) , S24–S6 (2006).
   PubMed Web of Science ®Google Scholar
• Lünemann JD , EdwardsN, MuraroPA et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain129(Pt 6) , 1493–1506 (2006).
   PubMed Web of Science ®Google Scholar
• Lindsey J , HatfieldL, CrawfordM, PatelS. Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis. Mult. Scler.15 , 153–158 (2009).
   PubMed Web of Science ®Google Scholar
• Serafini B , RosicarelliB, FranciottaD et al. Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2899–2912 (2007).
   PubMed Web of Science ®Google Scholar
• Willis SN , StadelmannC, RodigSJ et al. Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132(12) , 3318–3328 (2009).
   PubMedGoogle Scholar
• Sargsyan SA , ShearerAJ, RitchieAM et al. Absence of Epstein–Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74 , 1127–1135 (2010).
   PubMed Web of Science ®Google Scholar
• Tzartos JS , KhanG, VossenkamperA, Cruz-SadabaM et al. Association of innate immune activation with latent Epstein–Barr virus in active MS lesions. Neurology 78(1) , 15–23 (2012).
   PubMed Web of Science ®Google Scholar
• Peferoen LA , LamersF, LodderLN et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 133(Pt 5) , e137 (2010).
   PubMed Web of Science ®Google Scholar
• Otto C , OltmannA, SteinA et al. EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology 76(15) , 1316–1321 (2011).
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D . Epstein–Barr virus: exploiting the immune system. Nat. Rev. Immunol.1(1) , 75–82(2001).
   PubMed Web of Science ®Google Scholar
• Bryce J , Boschi-PintoC, ShibuyaK et al. WHO estimates of the causes of death in children. Lancet 365 , 1147–1152 (2005).
   PubMed Web of Science ®Google Scholar
• Gadoth N . Subacute sclerosing panencephalitis (SSPE) the story of a vanishing disease. Brain Dev. doi:10.1016/j.braindev.2011.12.008 (2012) (Epub ahead of print).
   PubMedGoogle Scholar
• Khalili K , WhiteMK, LublinF, FerranteP, BergerJR. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology68(13) , 985–990 (2007).
   PubMed Web of Science ®Google Scholar
• Stoner GL . Implications of progressive multifocal leukoencephalopathy and JC virus for the etiology of MS. Acta Neurol. Scand.83 , 20–33 (1991).
   PubMed Web of Science ®Google Scholar
• Yednock TA , CannonC, FritzLC et al. Prevention of experimental autoimmune encephalomyelitisis by antibodies against α4β1 integrin. Nature 356 , 63–66 (1992).
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK , TylerKL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med.353 , 369–374 (2005).
   PubMed Web of Science ®Google Scholar
• Langer-Gould A , AtlasSW, GreenAJ, BollenAW, PelletierD. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med.353 , 375–381 (2005).
   PubMed Web of Science ®Google Scholar
• Van Assche G , Van Ranst M, Sciot R et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn‘s disease. N. Engl. J. Med.353 , 362–368 (2005).
   PubMed Web of Science ®Google Scholar
• Herroelen L , de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet338(8776) , 1174–1175 (1991).
   PubMed Web of Science ®Google Scholar
• Konstantinou D , PaschalisC, MaraziotisT, DimopoulosP, BassarisH, SkoutelisA. Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient. Clin. Infect. Dis.33 , 1772–1773 (2001).
   PubMed Web of Science ®Google Scholar
• Vlacha V , FormanEN, MironD, PeterG. Recurrent thrombocytopenic purpura after repeated measles–mumps–rubella vaccination. Pediatrics97 , 738–739 (1996).
   PubMed Web of Science ®Google Scholar
• Rudick RA . Central nervous system complications of viral infections and vaccines. In: Cecil Textbook of Medicine 21st Edition. Goldman L, Claude Bennett J (Eds). Saunders, PA, USA, 2149–2151 (2000).
   Google Scholar
• Lévy-Bruhl D , DesenclosJC, RebièreI, DruckerJ. Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France. Vaccine20(16) , 2065–2071 (2002).
   PubMed Web of Science ®Google Scholar
• Schattner A . Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine23(30) , 3876–3886 (2005).
   PubMed Web of Science ®Google Scholar
• Farez MF , CorrealeJ. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J. Neurol.258(7) , 1197–1206 (2011).
   PubMed Web of Science ®Google Scholar
• DeStefano F , VerstraetenT, JacksonLA et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch. Neurol. 60(4) , 504–509 (2003).
   PubMedGoogle Scholar
• Verstraeten T , DavisR, DeStefanoF. Immunity to tetanus is protective against the development of multiple sclerosis. Med. Hypotheses65(5) , 966–969 (2005).
   PubMed Web of Science ®Google Scholar
• Goldberg SH , AlbrightAV, LisakRP, Gonzalez-ScaranoF. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol.5 , 134–139 (1999).
   PubMed Web of Science ®Google Scholar
• Berti R , BrennanMB, SoldanSS et al. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J. Neurovirol. 8 , 250–256 (2002).
   PubMed Web of Science ®Google Scholar
• Âlvarez-Lafuente R , Martín-EstefaníaC, De las Heras V et al. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol. Scand.105 , 95–99 (2002).
   PubMed Web of Science ®Google Scholar
• Giovannoni G , EbersG. Multiple sclerosis: the environment and causation. Curr. Opin. Neurol.20 , 261–268 (2007).
   PubMed Web of Science ®Google Scholar
• Soldan SS , BertiR, SalemN et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3 , 1394–1397 (1997).
   PubMed Web of Science ®Google Scholar
• Ablashi DV , LappsW, KaplanM et al. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult. Scler. 4 , 490–496 (1998).
   PubMed Web of Science ®Google Scholar
• Ongradi J , RajdaC, MarodiCL et al. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J. Neurovirol. 5 , 529–532 (1999).
   PubMed Web of Science ®Google Scholar
• Behzad-Behbahani A , MikaeiliMH, EntezamM et al. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J. Microbiol. Immunol. Infect. 44(4) , 247–251 (2011).
   PubMedGoogle Scholar
• Ahlgren C , OdenA, HaghighiS et al. The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome. J. Neuroimmunol. 235(1–2) , 98–103 (2011).
   PubMed Web of Science ®Google Scholar
• Ahlgren C , OdénA, BergströmT, LyckeJ. Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome. J. Neuroimmunol.247(1–2) , 70–74 (2012).
   PubMed Web of Science ®Google Scholar
• Brankin B , OsmanM, HerlihyL, HawkinsSA, CosbySL. Failure to detect measles virus RNA, by reverse transcription-polymerase chain reaction, in peripheral blood leucocytes of patients with multiple sclerosis. Mult. Scler.1(4) , 204–206 (1996).
   PubMedGoogle Scholar
• Bogdanovic G , PriftakisP, HammarinAL et al. Detection of JC virus in cerebrospinal fluid (CSF) samples from patients with progressive multifocal leukoencephalopathy but not in CSF samples from patients with herpes simplex encephalitis, enteroviral meningitis, or multiple sclerosis. J. Clin. Microbiol. 36(4) , 1137–1138 (1998).
   PubMed Web of Science ®Google Scholar
• Buckle GJ , GodecMS, RubiJU et al. Lack of JC viral genomic sequences in multiple sclerosis brain tissue by polymerase chain reaction. Ann. Neurol. 32(6) , 829–831 (1992).
   PubMed Web of Science ®Google Scholar
• Ferrante P , Omodeo-ZoriniE, Caldarelli-StefanoR et al. Detection of JC virus in cerebrospinal fluid of Multiple sclerosis patients. Mult. Scler. 4 , 49–54 (1998).
   PubMed Web of Science ®Google Scholar
• Koralnik IJ , BodenD, MaiVX, LordCI, LetvinNL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology52(2) , 253–260 (1999).
   PubMed Web of Science ®Google Scholar

Websites

• University of Utah Healthcare. Latest drug alerts and warnings. http://healthcare.utah.edu/pharmacy/alerts/333.htm
   Google Scholar
• National Multiple Sclerosis Society. www.nationalmssociety.org/living-withmultiple-sclerosis/healthy-living/vaccinations/index.aspx
   Google Scholar
• CDC. General Recommendations on Immunization. www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm
   Google Scholar
• CDC. 2012 Adult Immunization Schedule. www.cdc.gov/vaccines/recs/schedules/adult-schedule.htm
   Google Scholar